Print | Need Larger Text?

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2013-2018

2. Registrant Information.

Registrant Reference Number: 03152013- MCPA

Registrant Name (Full Legal Name no abbreviations): MCPA Task Force Three (members: Nufarm bv, Dow AgroSciences, Albaugh Inc.)

Address: 44 Tamarack Circle

City: Toronto

Prov / State: Ontario

Country: CANADA

Postal Code: M9P 3T9

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

PMRA Registration No.       PMRA Submission No. 2005-4106      EPA Registration No.

Product Name: MCPA Acid

• Active Ingredient(s)
  • MCPA (PRESENT AS ACID)

7. b) Type of formulation.

Application Information

8. Product was applied?

Unknown

9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform VII: Scientific Study

1. Study Reference

Title Incident Report Submission transmitting copy of 6a2 Notice for Harlan acute inhalation study titled "MCPA Dimethylamine Salt: 4-Week Inhalation Toxicity Study in the Rat"

Date 15-MAR-13

2. a) Is an extension needed to translate the document?

No

3. Type of incident identified in the study

New health or environmental hazard

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

The inhalation study provides information on the NOAEL following repeated inhalation exposure to the test substance over a 28-day period.

5. a) Was the study discontinued before completion?

No

5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

Unknown

For Registrant use only

7. Provide supplemental information here